Rome wasn’t built in a day… But there is another lesser-known type of keystone, one that plays an equally critical role in supporting the most revolutionary technology the world’s ever seen… artificial intelligence. And without it, the entire AI industry would collapse.

You must read this new presentation from Porter Stansberry.

C. Raymond Larkin, Jr. net worth and biography

C. Larkin, Jr. Biography and Net Worth

Director of Align Technology

C. Raymond Larkin, Jr., has served as a director of Align Technology since March 2004. In February 2006, Mr. Larkin was appointed as Chairman of the Board. He currently serves as a principal of Group Outcome L.L.C., a merchant banking firm concentrating on medical technologies. From 2001 to 2007, he served as a part time Venture Partner at Cutlass Capital, a venture capital firm. Prior to Group Outcome, Mr. Larkin was Chairman and CEO at Eunoe Inc., an investigative device for slowing and stopping progression of Alzheimer's disease. Prior to that, he was President and Chief Executive Officer of Nellcor Puritan Bennett, Inc., one of the world's preeminent respiratory products companies. Under Mr. Larkin's leadership over 15 years, Nellcor grew to nearly $1 billion in revenues through the development and introduction of pulse oximetry into worldwide use for patient safety monitoring, setting the standard of care for the respiratory-impaired patient. Mr. Larkin also held positions of increasing responsibility at Bentley Laboratories/American Hospital Supply from 1976 to 1983. He serves on the board of directors of Heartware, Inc., a medical device company developing implant devices for the treatment of advanced heart failure. Mr. Larkin received his B.S. degree in Industrial Management from LaSalle University.

What is C. Raymond Larkin, Jr.'s net worth?: The estimated net worth of C. Raymond Larkin, Jr. is at least $6.32 million as of August 15th, 2024. Larkin, Jr. owns 28,247 shares of Align Technology stock worth more than $6,323,656 as of November 21st. This net worth approximation does not reflect any other investments that Larkin, Jr. may own. Learn More about C. Raymond Larkin, Jr.'s net worth.
How do I contact C. Raymond Larkin, Jr.?: The corporate mailing address for Larkin, Jr. and other Align Technology executives is 2820 ORCHARD PARKWAY, SAN JOSE CA, 95134. Align Technology can also be reached via phone at (602) 742-2000 and via email at [email protected]. Learn More on C. Raymond Larkin, Jr.'s contact information.
Has C. Raymond Larkin, Jr. been buying or selling shares of Align Technology?: C. Raymond Larkin, Jr. has not been actively trading shares of Align Technology during the last ninety days. Most recently, on Thursday, August 15th, C Raymond Larkin, Jr. bought 6,500 shares of Align Technology stock. The stock was acquired at an average cost of $235.33 per share, with a total value of $1,529,645.00. Following the completion of the transaction, the director now directly owns 28,247 shares of the company's stock, valued at $6,647,366.51. Learn More on C. Raymond Larkin, Jr.'s trading history.
Who are Align Technology's active insiders?: Align Technology's insider roster includes Simon Beard (Director), Kevin Burns (CFO), Julie Coletti (SVP), Kevin Dallas (Director), Robert Fitzgerald (Director), Stuart Hockridge (SVP), Joseph Hogan (CEO), Joseph Lacob (Director), C. Larkin, Jr. (Director), John Morici (CFO), George Morrow (Director), Thomas Prescott (Director), Vamsi Pudipeddi (CMO), Zelko Relic (SVP), Andrea Saia (Director), Yuval Shaked (SVP), Julie Tay (SVP), Warren Thaler (Director), and Emory Wright (SVP). Learn More on Align Technology's active insiders.
Are insiders buying or selling shares of Align Technology?: During the last year, Align Technology insiders bought shares 1 times. They purchased a total of 6,500 shares worth more than $1,529,645.00. During the last year, insiders at the medical equipment provider sold shares 3 times. They sold a total of 27,524 shares worth more than $8,403,923.80. The most recent insider tranaction occured on August, 15th when Director C Raymond Larkin Jr bought 6,500 shares worth more than $1,529,645.00. Insiders at Align Technology own 0.6% of the company. Learn More about insider trades at Align Technology.
Information on this page was last updated on 8/15/2024.

C. Raymond Larkin, Jr. Insider Trading History at Align Technology

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/15/2024	Buy	6,500	$235.33	$1,529,645.00	28,247
5/13/2022	Buy	1,000	$264.42	$264,420.00	18,190
7/29/2021	Sell	2,500	$675.00	$1,687,500.00	18,667
7/14/2021	Sell	2,500	$650.00	$1,625,000.00
6/28/2021	Sell	5,000	$621.73	$3,108,650.00	26,210
5/7/2021	Sell	5,000	$598.70	$2,993,500.00	30,987
5/30/2019	Sell	9,734	$296.65	$2,887,591.10	50,257
5/7/2018	Sell	15,000	$264.45	$3,966,750.00	97,922
2/3/2017	Sell	15,000	$94.71	$1,420,650.00	92,012
5/5/2016	Sell	15,000	$74.36	$1,115,400.00	85,260
5/7/2015	Sell	15,000	$59.03	$885,450.00
10/28/2014	Sell	15,000	$51.54	$773,100.00

C. Raymond Larkin, Jr. Buying and Selling Activity at Align Technology

Align Technology Company Overview

Align Technology, Inc. designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth. The segment also provides Invisalign moderate, lite and express packages, and Invisalign go and Invisalign Go Plus; retention products, Invisalign training, and adjusting tools used by dental professionals during the course of treatment; and Invisalign Palatal Expander, a 3D printed orthodontic device; and 3D printing solutions. Its Imaging Systems and CAD/CAM Services segment offers iTero intraoral scanning system, a single hardware platform for restorative or orthodontic procedures; restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons; and orthodontists software for digital records storage, orthodontic diagnosis, and fabrication of printed models and retainers. This segment also provides Invisalign outcome simulator, a chair-side and cloud-based application for the iTero scanner; Invisalign progress assessment tool; Align Oral Health Suite, a digital interface designed to enhance dental consultations; and TimeLapse technology, which allows doctors or practitioners to compare a patient's historic 3D scans to the present-day scan, as well as subscription software, disposables, rentals, leases, pay per scan, and CAD/CAM software solutions. The company was incorporated in 1997 and is headquartered in Tempe, Arizona.

Today's Range

Now: $225.29

$224.43

$226.99

50 Day Range

MA: $228.90

$205.03

$257.17

2 Week Range

Now: $225.29

$196.09

$335.40

Volume

165,849 shs

Average Volume

781,503 shs

Market Capitalization

$16.82 billion

P/E Ratio

38.45

Dividend Yield

N/A

Beta

1.65

This company will win the AI race

From Porter & Company | Ad